Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days
CNBC· 8 小時前The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for ...
Trio shares Nobel Prize in physics for study on light
China Daily· 37 分鐘前The Nobel Prize in physics was awarded on Tuesday to three scientists who look at electrons in atoms during the tiniest ...
World Heart Day heightens public vigilance against cardiovascular diseases
HKSAR Government Press Releases· 4 日前The Department of Health (DH) today (September 29) urged members of the public to take positive steps to prevent and control ...
What Is Disease X? How Scientists Are Preparing for the Next Pandemic
Bloomberg· 7 日前It sounds like something Elon Musk might have cooked up: “Disease X.” In fact, the term was ...
Amgen's late-stage data for lung cancer drug 'not adequate' - FDA staff
Reuters· 9 小時前Lumakras, which bought in sales of $285 million last year, targets a mutated form of a gene ...
Study Links Dementia To Oral Health, Let’s talk Oral-Brain Connection
Forbes· 3 日前Periodontal disease, dental caries and a high number of missing teeth were associated with an increased ...
A New Technology Is Helping To Save The Florida Citrus Industry With A “Shot In The Arm”
Forbes· 5 日前There are some important plant diseases that are caused by bacteria and viruses and often these ...
U.S. FDA approves Amicus Therapeutics' muscle disorder treatment
Reuters· 6 日前Amicus Therapeutics on Thursday said the U.S. Food and Drug Administration (FDA) had approved its therapy to treat a muscle ...
US FDA authorizes Novavax's updated COVID shot
Reuters· 8 小時前The U.S. Food and Drug Administration on Tuesday authorized an updated version of Novavax's protein-based COVID-19 vaccine ...
Evercore ISI says this biotech stock is a high risk, high reward play, with more than 200% upside
CNBC· 9 小時前Evercore ISI initiated coverage of Aclaris Therapeutics , a clinical stage biotech working on immunology and inflammation ...
